9 ha a concurrent disease or condition or laboratory abnormality that in the view of the investigator place the subject at high risk of poor treatment compliance or of not complete the study or would interfere with study participation or introduces additional safety concern e.g. diabetes mellitus other concurrent neurological or psychiatric disorder 